Antibody responses following third mRNA COVID-19 vaccination in patients with cancer and potential timing of a fourth vaccination

Sidse Ehmsen, Anders Asmussen, Stefan S. Jeppesen, Anna Christine Nilsson, Sabina Østerlev, Amalie Kragh, Henrik Frederiksen, Henrik J. Ditzel*


Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

TidsskriftCancer Cell
Udgave nummer4
Sider (fra-til)338-339
StatusUdgivet - 11. apr. 2022

Bibliografisk note

Funding Information:
The study was supported by a grant from the Odense University Research Council . The funder had no role in study design, patient recruitment, data collection, data analysis, data interpretation, or writing of the report. We want to express our gratitude to the participants of the study; to laboratory technicians at the Odense University Department of Oncology for technical assistance with the blood samples; and to the Clinical Experimental Unit, Department of Oncology, Odense University Hospital for assistance with the recruitment of patients. We thank M.K. Occhipinti for editorial assistance.